Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

Leukemia

Volumn 26, Issue 5, 2012, Pages 1153-

  Kumar, S K ^a   Lee, J H ^a   Lahuerta, J J ^a   Morgan, G ^a   Richardson, P G ^a   Crowley, J ^a   Haessler, J ^a   Feather, J ^a   Hoering, A ^a   Moreau, P ^a   Leleu, X ^a   Hulin, C ^a   Klein, S K ^a   Sonneveld, P ^a   Siegel, D ^a   Bladee J ^a   Goldschmidt, H ^a   Jagannath, S ^a   Miguel, J S ^a   Orlowski, R ^a   Palumbo, A ^a   Sezer, O ^a   Rajkumar, S V ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 84860711612     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.15     Document Type: Erratum

References (0)